NAVIDEA BIOPHARMACEUTICALS, INC. (33)

Browse by Contract Category

Contracts

Form of Subscription Rights Certificate (Filed With SEC on August 2, 2022)
Form of Dealer-Manager Agreement (Filed With SEC on August 2, 2022)
Separation Agreement and General Release between the Company and Jed A. Latkin (Filed With SEC on November 26, 2021)
Termination Agreement by and among the Company, SpePharm and Norgine (Filed With SEC on May 12, 2020)
Form of Warrant Agency Agreement between Navidea Biopharmaceuticals, Inc. and Continental Stock Transfer & Trust Company, LLC (Filed With SEC on August 2, 2022)
Form of Common Stock Purchase Warrant to be issued in rights offering (Filed With SEC on August 2, 2022)
Certificate of Designations, Preferences and Rights of Series I Convertible Preferred Stock (Filed With SEC on August 2, 2022)
Form of Subscription Rights Certificate (Filed With SEC on July 20, 2022)
Form of Warrant Agency Agreement between Navidea Biopharmaceuticals, Inc. and Continental Stock Transfer & Trust Company, LLC (Filed With SEC on July 20, 2022)
Form of Common Stock Purchase Warrant to be issued in rights offering (Filed With SEC on July 20, 2022)
Certificate of Designations, Preferences and Rights of Series I Convertible Preferred Stock (Filed With SEC on July 20, 2022)
Registration Rights Agreement effective as of April 10, 2022 by and between Navidea Biopharmaceuticals, Inc. and John K. Scott, Jr (Filed With SEC on April 12, 2022)
Security Agreement dated as of April 10, 2022 by Navidea Biopharmaceuticals, Inc. in favor of John Kim Scott, Jr (Filed With SEC on April 12, 2022)
Secured Term Note, dated April 10, 2022 (Filed With SEC on April 12, 2022)
Stock Exchange and Loan Agreement between Investor and Navidea Biopharmaceuticals, Inc., dated April 10, 2022 (Filed With SEC on April 12, 2022)
Section 382 Rights Agreement, dated as of April 7, 2022, between Navidea Biopharmaceuticals, Inc. and Continental Stock Transfer & Trust Company, LLC, as Rights Agent (Filed With SEC on April 12, 2022)
Amendment to Stock Purchase Agreement and Letter of Investment Intent by and between the Company and Investor dated July 8, 2021 (Filed With SEC on July 13, 2021)
Registration Rights Agreement by and between the Company and Investor dated March 2, 2021 (Filed With SEC on March 4, 2021)
Stock Purchase Agreement and Letter of Investment Intent by and between the Company and Investor dated March 2, 2021 (Filed With SEC on March 4, 2021)
Form of Common Stock Purchase Agreement (Filed With SEC on September 2, 2020)
Stock Purchase Agreement and Letter of Investment Intent, by and between the Company and Keystone (Filed With SEC on September 2, 2020)
Amended and Restated Equity Commitment Letter, dated August 14, 2020, between Mastiff Group LLC and Navidea Biopharmaceuticals, Inc (Filed With SEC on August 14, 2020)
Stock Purchase Agreement, effective August 9, 2020, by and between Navidea Biopharmaceuticals, Inc. and Jubilant Radiopharma (Filed With SEC on August 12, 2020)
Employment Agreement, effective July 27, 2020, by and between Navidea Biopharmaceuticals, Inc. and Jed A. Latkin (Filed With SEC on July 31, 2020)
Stock Purchase Agreement and Letter of Investment Intent by and between the Company and the Investor (Filed With SEC on May 12, 2020)
Stock Purchase Agreement, effective February 14, 2020, by and between Navidea Biopharmaceuticals, Inc. and John K. Scott (Filed With SEC on March 18, 2020)
Stock Purchase Agreement, effective February 14, 2020, by and between Navidea Biopharmaceuticals, Inc. and Keystone Capital Partners, LLC (Filed With SEC on March 18, 2020)
Description of Securities (Filed With SEC on March 18, 2020)
Stock Purchase Agreement, dated December 6, 2019, among Navidea Biopharmaceuticals, Inc. and the purchasers named therein (Filed With SEC on December 11, 2019)
Registration Rights Agreement, dated December 6, 2019, among Navidea Biopharmaceuticals, Inc. and the stockholders named therein (Filed With SEC on December 11, 2019)
Underwriting Agreement, dated June 13, 2019, by and between Navidea Biopharmaceuticals, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on June 17, 2019)
Form of Underwriter Warrants of Navidea Biopharmaceuticals, Inc (Filed With SEC on June 17, 2019)
Stock Purchase Agreement, dated March 22, 2019, between Navidea Biopharmaceuticals, Inc. and John K. Scott, Jr (Filed With SEC on May 9, 2019)